4 - AMPK, mTOR, and more... Flashcards
1
Q
mTOR
A
-
PIKK (ser/thr kinase)
- that is expressed in ALL EUKARYOTIC organisms
- Mechanistic target of RAPAMYCIN
- responds to energy / AA / Oxygen levels
-
INSULIN induces mTOR signaling
- Regulates the regulation of energy
- Forms two complexes:
- mTORC1 = mtor + RAPTOR
- mTORC2 = mTOR + rictor
2
Q
mTORC1 3 Major Functions
A
-
Activates Ribosomal Proteins
- S6K -> actively translating more proteins
- Induces the dissocation of 4E-BP1 from elF4E
- 4E-BP1 normally is inhibiting elF4E
- –> Initiates mRNA Translation
- Stimulates Protein Synthesis
- –> Initiates mRNA Translation
- 4E-BP1 normally is inhibiting elF4E
- Inhibits Catabolic process of _AUTOPHAGY_
Ultimately increases
Cell mass / size / proliferation
3
Q
mTORC1 Activation pathway
A
-
Insulin Binding starts Signaling Cascade
- IRS-1 activates P13K
- Pip2-Pip3
- Activates PDK1
- Phosphoralates Ser/Thr AKT
-
Inhibits TSC1/2
- AMPK activates TSC
-
Inhibits RHEB conversion
- Activates mTORC1
-
Inhibits TSC1/2
- Phosphoralates Ser/Thr AKT
- Activates PDK1
4
Q
mTORC1 initiation of cap-dependent mRNA Translation
A
- mTORC1 activation causes dissociation of 4E-BP1 from elF4E
- allows elF4FE complex to form
- binds to 7-mg CAP on 5’ end of mRNA
- -> Initiate cap dependent mRNA Translation
- binds to 7-mg CAP on 5’ end of mRNA
- allows elF4FE complex to form
5
Q
Pathologies Associated With mTORC2
A
- Normally, PTEN** inhibits conversion of **P13K -> mTORC2
-
Cowden / Prostate CA / Endometrial CA / Giloblastoma
- All stop PTEN from inhibiting mTORC
- -> Turn ON TRANSLATION
- = Uncontrolled Growth
- -> Turn ON TRANSLATION
- All stop PTEN from inhibiting mTORC
-
Cowden / Prostate CA / Endometrial CA / Giloblastoma
6
Q
PTEN / LKB1 / NF1 / VHL
A
- Proteins that are signaled by Oxygen/energy/hormones
- to INHIBIT mTORC1
- to CONTROL translation & Protein synthesis
- to INHIBIT mTORC1
- Various pathologies cause the Loss of the proteins
-
–> Activation of mTORC1
- -> Uncontrolled Growth / Cancer
-
–> Activation of mTORC1
7
Q
Rapamycin
A
- pharmacological Inhibitor of mTOR
- Macrocyclic Lactone
- Induces Dimerization of mTOR / FKB12
- -> loss of signaling from interacting proteins
- Immunosuppresive Functions
8
Q
Rapamycin Uses
A
-
Immunosuppresive Function
- blocks IL2 mediated T-cell proliferation
-
Prevent Restenosis in Coronary Stents
- potent inhibitor of vascular smooth muscle proliferation
- keeps vascular smooth muscle from growing around the stent
- potent inhibitor of vascular smooth muscle proliferation
- INHIBITS proliferation of many CANCER cells
9
Q
Immunosuppressive Function of
Rapamycin = mTOR Inhibitor
A
- Normally mTOR allows for T-cell proliferation
- –> cell-cycle progression of IL-2 production
- -> Cascade of immunogenic events
- –> cell-cycle progression of IL-2 production
-
Inhibiting mTOR
-
-> blocks IL-2 activation of T / B Cells
- reduces the Immune Response
-
-> blocks IL-2 activation of T / B Cells
10
Q
Prevention of Restenosis
Rapamycin = mTOR Inhibitor
A
- Restenosis = Inflammation of the area around the STENT
- Caused by the Proliferation of smooth muscle cells
-
mTOR Inhibition -> BLOCKS cell replication
- blocks muscle cell migration & proliferation of smooth muscle cells
11
Q
Dual Effect of Rapalogs in Type 1 Diabetes
A
- Type 1 diabetes is treated by transplanting a pancreas or islet cells
- Inhibiting mTOR results in:
-
Preventing the rejection of beta islet cells
-
but hinder islet health
- b/c mTOR normally signals islet growth through S6K
-
but hinder islet health
-
Stopping the positive regulation of islet proliferation
- mTOR normally promotes islet proliferation
-
Preventing the rejection of beta islet cells
12
Q
Rapalog
A
Rapamycin + its analogs
Alter PK/PD of Rapamycin
INHIBITS mTOR
13
Q
Rapalogs in Type 2 Diabetes
A
- Rapamycin -> blocks S6K
- can help restore sensitivity
- S6K negatively inhibits Insulin receptors
- can help restore sensitivity
-
Sustained mTOR activation is one mechanism of INSULIN RESISTANCE
- from a reduction of downstream signaling of insulin receptor changes in phosphorylation
- can also degrade IRS2
- -> beta cell apoptosis
14
Q
How does mTOR cause insulin resistance?
A
- Normally, Insulin or Glucose Binding
-
Activates mTORC1 -> S6K
-
S6K inhibits IRS insulin receptor
- = Normal Negative feedback
-
S6K inhibits IRS insulin receptor
-
Activates mTORC1 -> S6K
- In T2DM,
- Glucose + Obesity + Cytokines are constantly activating mTORC1
-
-> S6K is constantly inhibiting the insulin receptor
- -> INSULIN RESISTANCE
-
-> S6K is constantly inhibiting the insulin receptor
- Glucose + Obesity + Cytokines are constantly activating mTORC1
15
Q
AMPK-5’
A
- Heterotrimeric Ser-Thr Kinase
- Senses DEPLETION of intracellular energy
- -> stimulates ATP GENERATION
- = Catabolic
- -> stimulates ATP GENERATION
- Senses DEPLETION of intracellular energy
- Allosterically activated by AMP
- Covalently modified by phosphorylation by LEPTIN